Willis Towers Watson saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 67 to 72.
IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks compares to all the other stocks in our database.
History reveals that the market's biggest winners typically have an 80 or higher RS Rating as they begin their biggest price moves. See if Willis Towers Watson can continue to rebound and hit that benchmark.
How To Invest In Stocks In Both Bull And Bear Markets
Willis Towers Watson is building a cup without handle with a 278.86 buy point. See if it can clear the breakout price in volume at least 40% above average.
Willis Towers Watson posted 16% EPS growth in its most recent report, while sales growth came in at 4%.
Willis Towers Watson holds the No. 8 rank among its peers in the Insurance-Brokers industry group. Ryan Specialty Holdings, Baldwin Insurance Cl A and Brown & Brown are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
